Рынок медицинской марихуаны в Северной Америке – тенденции отрасли и прогноз до 2030 года

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Рынок медицинской марихуаны в Северной Америке – тенденции отрасли и прогноз до 2030 года

  • Pharmaceutical
  • Published Report
  • May 2023
  • North America
  • 350 Pages
  • Количество таблиц: 372
  • Количество рисунков: 53

North America Medical Cannabis Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
2024 –2030
Diagram Размер рынка (базовый год)
МИЛЛИОН ДОЛЛАРОВ США
Diagram Размер рынка (прогнозируемый год)
МИЛЛИОН ДОЛЛАРОВ США
Diagram CAGR
%
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>Рынок медицинской марихуаны в Северной Америке, по видам продукции (масло, капсулы медицинской марихуаны, пластырь, цельные цветы, молотые цветы, вейп-ручки, сушеная медицинская марихуана, кремы и увлажняющие средства, маски и сыворотки, очищающие средства и другие), источник (натуральный и синтетический), виды (Cannabis Indica, Sativa и гибрид), применение ( болезнь Альцгеймера , потеря аппетита, рак, воспалительные заболевания кишечника, расстройства пищевого поведения, эпилепсия, аутизм, психические заболевания, рассеянный склероз, лечение боли, тошнота, мышечные спазмы, синдром истощения (кахексия), повышение настроения, депрессия и расстройства сна, тревожность и другие), производные (каннабидиол (КБД), тетрагидроканнабинол (ТГК)/дельта-8-тетрагидроканнабинол, каннабинол (CBN), каннабициклол (CBL), каннабихромен (CBC), каннабигерол (CBG) и другие), тип лечения (отхаркивающее, противовирусное, анальгетическое, афродизиак, психоделическое и другие), способ применения (пероральные растворы и капсулы, курение, испарители, местные средства и другие), конечный пользователь (фармацевтическая промышленность, научно-исследовательские и опытно-конструкторские центры, учреждения по уходу на дому, больницы, реабилитационные центры и другие), канал распространения (B2B и B2C) — тенденции отрасли и прогноз до 2030 года.

Рынок медицинской марихуаны в Северной Америке

Анализ и информация о рынке медицинской марихуаны в Северной Америке

Рост числа пациентов, связанных с хроническими заболеваниями в Северной Америке, и возросшая склонность к здоровому образу жизни являются некоторыми из факторов, которые, как ожидается, будут стимулировать рост рынка. Кроме того, ожидается, что рост числа одобрений продуктов и увеличение научно-исследовательских и опытно-конструкторских работ для медицинских устройств с каннабисом будут стимулировать рост рынка. Однако высокая стоимость медицинских устройств и процедур с каннабисом, лекарственных препаратов, проблемы безопасности и побочные эффекты, связанные с лазерными процедурами, а также недостаточная осведомленность о лечении лазерными устройствами, как ожидается, будут сдерживать рост рынка. Ожидается, что дополнительные технологические достижения в области медицинского каннабиса и стратегические инициативы новых игроков станут возможностями для роста рынка. Однако ожидается, что строгие правила и нехватка квалифицированных специалистов станут проблемой для роста рынка.

Рынок медицинской марихуаны в Северной Америке

Рынок медицинской марихуаны в Северной Америке

Использование каннабиса в качестве лекарства не подвергается строгому тестированию из-за правительственных ограничений, что приводит к ограничению клинических исследований для определения эффективности каннабиса в медицинских и клинических применениях. Однако предварительные исследования показывают, что каннабис уменьшает рвоту и тошноту у пациентов, проходящих химиотерапию, и помогает повысить аппетит.

По данным исследования рынка Data Bridge, ожидается, что среднегодовой темп роста рынка медицинской марихуаны в Северной Америке составит 23,2% в прогнозируемый период с 2023 по 2030 год.

Отчет Метрика

Подробности

Прогнозируемый период

2023-2030

Базовый год

2022

Исторический год

2021 (Можно настроить на 2015–2020)

Количественные единицы

Доход в млн. долл. США

Охваченные сегменты

Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C)

Countries Covered

U.S., Canada, and Mexico

Market Players Covered

MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis North America Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol North America Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others

Market Definition

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has a wide range of applications in the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer’s among others.

The increased medicinal use of cannabis, the controlled legalization and use of cannabis in various industries, and the advanced methodologies present in the field are some of the factors expected to drive market growth.

North America Medical Cannabis Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

  • Increased use of cannabis in medicines

Medicinal cannabis is derived from cannabis plants and can be used to treat symptoms of certain medical conditions, and the side effects of some treatments. The most common form of medicinal use of cannabis is pain management. There has been gradual acceptance and use of medicinal cannabis with the growing number of countries that have legalized the use of cannabis for various indications. Medical cannabis has been approved for use by the FDA for three indications which are rare and severe forms of epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome and also to treat the spasticity in Multiple Sclerosis (MS).

Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions apart from the approved drugs, there is an increased interest in two cannabinoids which are delta-9-tetrahydrocannabinol and cannabidiol. Tetrahydrocannabinol is shown to improve appetite, minimize fatigue, and manage muscle function issues while cannabidiol is effective for managing epileptic seizures, curing psychiatric illness, and reducing inflammation.

  • Legalization of Cannabis

The use and acceptance of medicinal cannabis continue to evolve, as the growing number of states are permitting the use of specific medical indications. Many countries have legalized marijuana for either medicinal or recreational purposes while some other countries with restricted use. In recent years, a growing number of states in the U.S. have legalized the drug for medical or recreational purposes. With the widespread legalization of cannabis, many companies are also becoming proactive and are taking initiatives for the complete legalization of cannabis.

The legalization of marijuana in different parts of the world can be seen as an effort to increase the additional revenue, this way there will be a boost in the revenue without raising taxes. The legalization of cannabis will allow more consumption of it for medicinal or recreational purposes. Moreover, it will also boost the cannabis business, thus creating more demand for cannabis. Hence, the legalization of cannabis is expected to drive market growth.

Opportunities

  • Novel product development with increasing R&D activities

Medicinal cannabis comes in many different forms including capsules, chewable gum, creams, crystals, flower, lozenges, oil, and oro-mucosal sprays. High growth in the demand for cannabis with legalization has increased the need to come up with better product strains and delivery systems. This has led many companies to conduct R&D activities to check the genetic improvement strategies for cannabis. The FDA's Cannabis Product Committee (CPC) develops and implements cross-Agency strategies and policies for the regulation of cannabis products. The novel products that are developed and on the rise are hemp protein powders, energy bars, hemp milk, hemp flour, and hemp tea, which are expected to create opportunities for market growth.

  • Increased adoption of cannabis for recreational purpose

Legalizing recreational marijuana results in helpful regulation of a safe drug, without increasing potential negative consequences. The legalization of marijuana has various societal benefits as the rise in the economy without increasing taxes, creating thousands of job opportunities, stopping the racial differences in marijuana enforcement, and freeing up scarce police resources. Legal recreational marijuana can end the costly enforcement of marijuana laws and debilitate the illegal marijuana market.

Due to these benefits, marijuana has been legalized and is being increasingly adopted by people of different age groups. This creates a demand for good-quality marijuana for fun and relaxation. Hence, the increasing adoption of cannabis for recreational purposes is expected to create opportunities for manufacturers in the market.

Restraint/Challenge

  • High-cost purchasing and rush for premium quality

Medical cannabis devices can be expensive to manufacture and purchase, and the procedure cost can also be high due to the specialized equipment and training required. This can limit the accessibility of medical cannabis treatments for patients and healthcare facilities, particularly in lower-income regions. Additionally, the high cost of medical cannabis devices and procedures may deter some patients from choosing these treatments, especially if they have to pay out of pocket. Insurance coverage for medical cannabis treatments can also be limited, limiting their adoption.

As a result, the high cost of medical cannabis devices and procedures can be a significant barrier to market growth, especially in regions where cost is a major factor. However, as technology advances, the cost of these devices and procedures may decrease, making them more accessible to patients and healthcare facilities.

The increased intricacy of medical cannabis devices and the high cost of medical cannabis treatment are expected to restrain the market growth.

Recent Development

  • In May 2018, as per the Cannabis Act of the Government of Canada, the cannabis act will create a strict legal framework for controlling the production, distribution, sale, and possession of cannabis across Canada which is meant to keep cannabis out of the hands of youth and profits out of pockets of organized crime by fostering a robust legal and regulated industry.

North America Medical Cannabis Market Scope

The North America medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Oil
  • Dried Medical Cannabis
  • Medical Cannabis Capsules
  • Vape Pen
  • Whole Flower
  • Creams & Moisturizer
  • Ground Flower
  • Patch
  • Masks & Serum
  • Cleanser
  • Others

On the basis of product, the market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, masks & serum, cleanser, and others.

Source

  • Synthetic
  • Natural

On the basis of source, the market is segmented into synthetic and natural.

Species

  • Cannabis Indica
  • Sativa
  • Hybrid

On the basis of species, the market is segmented into cannabis indica, sativa, and hybrid.

Derivatives

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol
  • Cannabigerol (CBG)
  • Cannabichromene (CBC)
  • Cannabinol (CBN)
  • Cannabicyclol (CBL)
  • Others

On the basis of derivatives, the market is segmented into Cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and others.

Application

  • Pain Management
  • Anxiety
  • Muscle Spasm
  • Nausea
  • Appetite Loss
  • Eating Disorders
  • Inflammatory Bowel Diseases
  • Cancer
  • Arthritis
  • Wasting Syndrome (Cachexia)
  • Alzheimer’s Disease
  • Epilepsy
  • Depression and Sleep Disorder
  • Multiple Sclerosis
  • Autism
  • Mental Health Conditions
  • Elevate Mood
  • Others

On the basis of application, the market is segmented into Alzheimer’s disease, appetite loss, cancer, inflammatory bowel diseases, eating disorders, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, wasting syndrome (cachexia), elevate mood, multiple sclerosis, depression and sleep disorders, anxiety, and others.

Route of Administration

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others

On the basis of route of administration, the market is segmented into oral solutions and capsules, smoking, vaporizers, topicals, and others.

Treatment Type

  • Analgesic
  • Psychedelic
  • Antiviral
  • Aphrodisiac
  • Expectorant
  • Others

On the basis of treatment type, the market is segmented into expectorant, antiviral, analgesic, aphrodisiac, psychedelic, and others.

End User

  • Homecare Setting
  • Hospital
  • Rehab Centers
  • Pharmaceutical Industry
  • Research and Development Centers
  • Others

On the basis of end user, the market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital, rehab centers, and others.

Distribution Channel

  • B2B
  • B2C

On the basis of distribution channel, the market is segmented into B2B and B2C.

Рынок медицинской марихуаны в Азиатско-Тихоокеанском регионе

North America Medical Cannabis Market Regional Analysis/Insights

The North America medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.

The countries covered in this market report are U.S., Canada, and Mexico.

The U.S. is expected to dominate the North America medical cannabis market due to the legalization of medical cannabis use.

Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании на внутреннем рынке, которые влияют на текущие и будущие тенденции рынка. Такие данные, как новые продажи, заменяющие продажи, демографические данные страны, нормативные акты и импортно-экспортные тарифы, являются одними из основных указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по стране учитываются наличие и доступность региональных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, а также влияние каналов продаж.

Конкурентная среда и анализ доли рынка медицинской марихуаны в Северной Америке

Конкурентная среда рынка медицинской марихуаны в Северной Америке содержит сведения о конкурентах. Включены сведения о компании, финансах компании, полученном доходе, рыночном потенциале, инвестициях в НИОКР, новых рыночных инициативах, региональном присутствии, производственных площадках и объектах, сильных и слабых сторонах компании, запуске продукта, клинических испытаниях, анализе бренда, одобрении продукта, патентах, широте и широте продукта, доминировании приложений и кривой жизненной линии технологий. Приведенные выше данные относятся только к фокусу компаний на рынке.

Некоторые из основных игроков рынка, работающих на этом рынке, включают MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis North America Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol North America Limited, ENDOCA, Harmony, MARY'S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma и IDT Australia и другие.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE NORTH AMERICA MEDICAL CANNABIS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 INDUSTRY INSIGHTS

5.1 INDUSTRY INSIGHTS PATENT ANALYSIS

5.2 DRUG TREATMENT RATE BY MATURED MARKETS

5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES

5.4 PATIENT FLOW DIAGRAM

5.5 KEY PRICING STRATEGIES

5.6 KEY PATIENT ENROLLMENT STRATEGIES

6 REGULATORY SCENARIO

6.1 U.S.

6.2 CANADA

6.3 MEXICO

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASED USE OF CANNABIS IN MEDICINES

7.1.2 LEGALIZATION OF CANNABIS

7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS

7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS

7.2 RESTRAINTS

7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS

7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE

7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY

7.3 OPPORTUNITIES

7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES

7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES

7.3.3 GROWING GERIATRIC POPULATION

7.4 CHALLENGES

7.4.1 RISE OF THE CANNABIS BLACK MARKET

7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS

7.4.3 SHORTAGE OF SKILLED PERSONNEL

8 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 OIL

8.2.1 OIL, BY TYPE

8.2.1.1 CBD OIL CONCENTRATES

8.2.1.2 CBD VAPE OIL

8.2.1.3 CBD TINCTURES

8.2.2 OIL, BY SOURCE

8.2.2.1 HEMP BASED

8.2.2.2 MARIJUANA BASED

8.2.3 OIL, BY SPECIES

8.2.3.1 SATIVA

8.2.3.2 HYBRID

8.2.3.3 CANNABIS INDICA

8.2.4 OIL, BY PRODUCT TYPE

8.2.4.1 BRANDED

8.2.4.1.1 PENGUIN CBD OIL

8.2.4.1.2 FAB CBD OIL

8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL

8.2.4.1.4 OTHERS

8.2.4.2 GENERIC

8.3 DRIED MEDICAL CANNABIS

8.3.1 CANNABIS INDICA

8.3.2 SATIVA

8.3.3 HYBRID

8.4 MEDICAL CANNABIS CAPSULES

8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE

8.4.1.1 OIL BASED CANNABIS CAPSULES

8.4.1.2 POWDER BASED CANNABIS CAPSULES

8.4.1.3 LIQUID BASED CANNABIS CAPSULES

8.4.1.4 OTHERS

8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES

8.4.2.1 HIGH CBD CAPSULES DIGITAL

8.4.2.2 HIGH THC CAPSULE

8.4.2.3 THC/CBD BALANCED CAPSULE

8.4.2.4 CBD ISOLATE CAPSULE

8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES

8.4.3.1 SATIVA

8.4.3.2 CANNABIS INDICA

8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE

8.4.4.1 BRANDED

8.4.4.1.1 JOY NUTRITION

8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES

8.4.4.1.3 LAZARUS NATURALS

8.4.4.1.4 OTHERS

8.4.4.2 GENERIC

8.5 VAPE PEN

8.5.1 VAPE PEN, BY SPECIES

8.5.1.1 SATIVA

8.5.1.2 HYBRID

8.5.1.3 CANNABIS INDICA

8.5.2 VAPE PEN, BY PRODUCT TYPE

8.5.2.1 BRANDED

8.5.2.1.1 KANDYPENS RUBI

8.5.2.1.2 SOL E-NECTAR COLLECTOR

8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN

8.5.2.2 GENERIC

8.6 WHOLE FLOWER

8.6.1 WHOLE FLOWER, SPECIES

8.6.1.1 SATIVA

8.6.1.2 HYBRID

8.6.1.3 CANNABIS INDICA

8.6.2 WHOLE FLOWER, PRODUCT TYPE

8.6.2.1 BRANDED

8.6.2.1.1 ASTER FARMS

8.6.2.1.2 RA FLOWER

8.6.2.1.3 BAD APPLE

8.6.2.2 GENERIC

8.7 CREAMS & MOISTURIZER

8.7.1 CREAMS & MOISTURIZER, BY SPECIES

8.7.1.1 SATIVA

8.7.1.2 HYBRID

8.7.1.3 CANNABIS INDICA

8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE

8.7.2.1 BRANDED

8.7.2.1.1 CBDFX MUSCLE & JOINT

8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM

8.7.2.1.3 MEDTERRA PAIN CREAM

8.7.2.2 GENERIC

8.8 GROUND FLOWER

8.8.1 GROUND FLOWER, BY SPECIES

8.8.1.1 SATIVA

8.8.1.2 HYBRID

8.8.1.3 CANNABIS INDICA

8.8.2 GROUND FLOWER, BY PRODUCT TYPE

8.8.2.1 BRANDED

8.8.2.1.1 ASTER FARMS

8.8.2.1.2 RA FLOWER

8.8.2.1.3 BAD APPLE

8.8.2.2 GENERIC

8.9 PATCH

8.9.1 PATCH, BY TYPE

8.9.1.1 RESERVOIR

8.9.1.2 LAYER DRUG-IN-ADHESIVE

8.9.1.3 OTHERS

8.9.2 PATCH, BY SPECIES

8.9.2.1 SATIVA

8.9.2.2 CANNABIS INDICA

8.9.2.3 HYBRID

8.9.3 PATCH, BY PRODUCT TYPE

8.9.3.1 BRANDED

8.9.3.1.1 HEMP BOMBS

8.9.3.1.2 PUREKANA

8.9.3.1.3 PURE RATIOS

8.9.3.1.4 RESERVOIR

8.9.3.2 GENERIC

8.1 MASKS & SERUM

8.10.1 MASKS & SERUM, BY SPECIES

8.10.1.1 SATIVA

8.10.1.2 CANNABIS INDICA

8.10.1.3 HYBRID

8.10.2 MASKS & SERUM, BY PRODUCT TYPE

8.10.2.1 BRANDED

8.10.2.1.1 BUMP & SMOOTH CBD

8.10.2.1.2 FACIAL ESSENCE

8.10.2.1.3 OTHERS

8.10.2.2 GENERIC

8.11 CLEANSER

8.11.1 CLEANSER, BY SPECIES

8.11.1.1 SATIVA

8.11.1.2 HYBRID

8.11.1.3 CANNABIS INDICA

8.11.2 CLEANSER, BY PRODUCT TYPE

8.11.2.1 BRANDED

8.11.2.1.1 KIEHL’S

8.11.2.1.2 CBD 101

8.11.2.1.3 OTHERS

8.11.2.2 GENERIC

8.12 OTHERS

9 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES

9.1 OVERVIEW

9.2 SATIVA

9.3 HYBRID

9.4 CANNABIS INDICA

10 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES

10.1 OVERVIEW

10.2 CANNABIDIOL (CBD)

10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL

10.4 CANNABIGEROL (CBG)

10.5 CANNABICHROMENE (CBC)

10.6 CANNABINOL (CBN)

10.7 CANNABICYCLOL (CBL)

10.8 OTHERS

11 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 PAIN MANAGEMENT

11.2.1 PAIN MANAGEMENT, BY TYPE

11.2.1.1 CHRONIC PAIN

11.2.1.2 NON-CANCER CHRONIC PAIN

11.2.1.3 NEUROLOGICAL PAIN

11.2.2 PAIN MANAGEMENT, BY PRODUCT

11.2.2.1 OIL

11.2.2.2 DRIED MEDICAL CANNABIS

11.2.2.3 MEDICAL CANNABIS CAPSULES

11.2.2.4 PATCH

11.2.2.5 GROUND FLOWER

11.2.2.6 CREAMS & MOISTURIZER

11.2.2.7 VAPE PEN

11.2.2.8 WHOLE FLOWER

11.2.2.9 MASKS & SERUM

11.2.2.10 CLEANSER

11.2.2.11 OTHERS

11.3 ANXIETY

11.3.1 OIL

11.3.2 DRIED MEDICAL CANNABIS

11.3.3 MEDICAL CANNABIS CAPSULES

11.3.4 PATCH

11.3.5 GROUND FLOWER

11.3.6 CREAMS & MOISTURIZER

11.3.7 VAPE PEN

11.3.8 WHOLE FLOWER

11.3.9 MASKS & SERUM

11.3.10 CLEANSER

11.3.11 OTHERS

11.4 MUSCLE SPASM

11.4.1 OIL

11.4.2 DRIED MEDICAL CANNABIS

11.4.3 MEDICAL CANNABIS CAPSULES

11.4.4 PATCH

11.4.5 GROUND FLOWER

11.4.6 CREAMS & MOISTURIZER

11.4.7 VAPE PEN

11.4.8 WHOLE FLOWER

11.4.9 MASKS & SERUM

11.4.10 CLEANSER

11.4.11 OTHERS

11.5 NAUSEA

11.5.1 OIL

11.5.2 DRIED MEDICAL CANNABIS

11.5.3 MEDICAL CANNABIS CAPSULES

11.5.4 PATCH

11.5.5 GROUND FLOWER

11.5.6 CREAMS & MOISTURIZER

11.5.7 VAPE PEN

11.5.8 WHOLE FLOWER

11.5.9 MASKS & SERUM

11.5.10 CLEANSER

11.5.11 OTHERS

11.6 APPETITE LOSS

11.6.1 OIL

11.6.2 DRIED MEDICAL CANNABIS

11.6.3 MEDICAL CANNABIS CAPSULES

11.6.4 PATCH

11.6.5 GROUND FLOWER

11.6.6 CREAMS & MOISTURIZER

11.6.7 VAPE PEN

11.6.8 WHOLE FLOWER

11.6.9 MASKS & SERUM

11.6.10 CLEANSER

11.6.11 OTHERS

11.7 EATING DISORDERS

11.7.1 OIL

11.7.2 DRIED MEDICAL CANNABIS

11.7.3 MEDICAL CANNABIS CAPSULES

11.7.4 PATCH

11.7.5 GROUND FLOWER

11.7.6 CREAMS & MOISTURIZER

11.7.7 VAPE PEN

11.7.8 WHOLE FLOWER

11.7.9 MASKS & SERUM

11.7.10 CLEANSER

11.7.11 OTHERS

11.8 INFLAMMATORY BOWEL DISEASES

11.8.1 OIL

11.8.2 DRIED MEDICAL CANNABIS

11.8.3 MEDICAL CANNABIS CAPSULES

11.8.4 PATCH

11.8.5 GROUND FLOWER

11.8.6 CREAMS & MOISTURIZER

11.8.7 VAPE PEN

11.8.8 WHOLE FLOWER

11.8.9 MASKS & SERUM

11.8.10 CLEANSER

11.8.11 OTHERS

11.9 CANCER

11.9.1 OIL

11.9.2 DRIED MEDICAL CANNABIS

11.9.3 MEDICAL CANNABIS CAPSULES

11.9.4 PATCH

11.9.5 GROUND FLOWER

11.9.6 CREAMS & MOISTURIZER

11.9.7 VAPE PEN

11.9.8 WHOLE FLOWER

11.9.9 MASKS & SERUM

11.9.10 CLEANSER

11.9.11 OTHERS

11.1 ARTHRITIS

11.10.1 OIL

11.10.2 DRIED MEDICAL CANNABIS

11.10.3 MEDICAL CANNABIS CAPSULES

11.10.4 PATCH

11.10.5 GROUND FLOWER

11.10.6 CREAMS & MOISTURIZER

11.10.7 VAPE PEN

11.10.8 WHOLE FLOWER

11.10.9 MASKS & SERUM

11.10.10 CLEANSER

11.10.11 OTHERS

11.11 WASHING SYNDROME (CACHEXIA)

11.11.1 OIL

11.11.2 DRIED MEDICAL CANNABIS

11.11.3 MEDICAL CANNABIS CAPSULES

11.11.4 PATCH

11.11.5 GROUND FLOWER

11.11.6 CREAMS & MOISTURIZER

11.11.7 VAPE PEN

11.11.8 WHOLE FLOWER

11.11.9 MASKS & SERUM

11.11.10 CLEANSER

11.11.11 OTHERS

11.12 ALZHEIMER’S DISEASE

11.12.1 OIL

11.12.2 DRIED MEDICAL CANNABIS

11.12.3 MEDICAL CANNABIS CAPSULES

11.12.4 PATCH

11.12.5 GROUND FLOWER

11.12.6 CREAMS & MOISTURIZER

11.12.7 VAPE PEN

11.12.8 WHOLE FLOWER

11.12.9 MASKS & SERUM

11.12.10 CLEANSER

11.12.11 OTHERS

11.13 EPILEPSY

11.13.1 OIL

11.13.2 DRIED MEDICAL CANNABIS

11.13.3 MEDICAL CANNABIS CAPSULES

11.13.4 PATCH

11.13.5 GROUND FLOWER

11.13.6 CREAMS & MOISTURIZER

11.13.7 VAPE PEN

11.13.8 WHOLE FLOWER

11.13.9 MASKS & SERUM

11.13.10 CLEANSER

11.13.11 OTHERS

11.14 DEPRESSION AND SLEEP DISORDER

11.14.1 OIL

11.14.2 DRIED MEDICAL CANNABIS

11.14.3 MEDICAL CANNABIS CAPSULES

11.14.4 PATCH

11.14.5 GROUND FLOWER

11.14.6 CREAMS & MOISTURIZER

11.14.7 VAPE PEN

11.14.8 WHOLE FLOWER

11.14.9 MASKS & SERUM

11.14.10 CLEANSER

11.14.11 OTHERS

11.15 MULTIPLE SCLEROSIS

11.15.1 OIL

11.15.2 DRIED MEDICAL CANNABIS

11.15.3 MEDICAL CANNABIS CAPSULES

11.15.4 PATCH

11.15.5 GROUND FLOWER

11.15.6 CREAMS & MOISTURIZER

11.15.7 VAPE PEN

11.15.8 WHOLE FLOWER

11.15.9 MASKS & SERUM

11.15.10 CLEANSER

11.15.11 OTHERS

11.16 AUTISM

11.16.1 OIL

11.16.2 DRIED MEDICAL CANNABIS

11.16.3 MEDICAL CANNABIS CAPSULES

11.16.4 PATCH

11.16.5 GROUND FLOWER

11.16.6 CREAMS & MOISTURIZER

11.16.7 VAPE PEN

11.16.8 WHOLE FLOWER

11.16.9 MASKS & SERUM

11.16.10 CLEANSER

11.16.11 OTHERS

11.17 MENTAL HEALTH CONDITIONS

11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)

11.17.1.2 SCHIZOPHRENIA

11.17.1.3 OTHERS

11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE

11.17.2.1 OIL

11.17.2.2 DRIED MEDICAL CANNABIS

11.17.2.3 MEDICAL CANNABIS CAPSULES

11.17.2.4 PATCH

11.17.2.5 GROUND FLOWER

11.17.2.6 CREAMS & MOISTURIZER

11.17.2.7 VAPE PEN

11.17.2.8 WHOLE FLOWER

11.17.2.9 MASKS & SERUM

11.17.2.10 CLEANSER

11.17.2.11 OTHERS

11.18 ELEVATE MOOD

11.18.1 OIL

11.18.2 DRIED MEDICAL CANNABIS

11.18.3 MEDICAL CANNABIS CAPSULES

11.18.4 PATCH

11.18.5 GROUND FLOWER

11.18.6 CREAMS & MOISTURIZER

11.18.7 VAPE PEN

11.18.8 WHOLE FLOWER

11.18.9 MASKS & SERUM

11.18.10 CLEANSER

11.18.11 OTHERS

11.19 OTHERS

12 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION

12.1 OVERVIEW

12.2 ORAL SOLUTIONS AND CAPSULES

12.3 SMOKING

12.4 TOPICALS

12.5 VAPORIZERS

12.6 OTHERS

13 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE

13.1 OVERVIEW

13.2 ANALGESIC

13.3 PSYCHEDELIC

13.4 ANTIVIRAL

13.5 APHRODISIAC

13.6 EXPECTORANT

13.7 OTHERS

14 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOMECARE SETTING

14.3 HOSPITAL

14.4 REHAB CENTERS

14.5 PHARMACEUTICAL INDUSTRY

14.6 RESEARCH AND DEVELOPMENT CENTERS

14.7 OTHERS

15 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 B2C

15.2.1 PHARMACIES

15.2.2 CONVENTIONAL STORES

15.2.3 ONLINE STORES

15.2.4 OTHERS

15.3 B2B

16 NORTH AMERICA MEDICAL CANNABIS MARKET, BY REGION

16.1 NORTH AMERICA

16.1.1 U.S.

16.1.2 CANADA

16.1.3 MEXICO

17 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE

17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

18 COMPANY PROFILE

18.1 MEDIPHARM LABS INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 TILRAY

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 AURORA CANNABIS

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 HEXO CORP. (ZENABIS NORTH AMERICA LTD)

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 APOTHECANNA

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 BOL PHARMA

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 BARNEY’S FARM

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 CANOPY GROWTH CORPORATION

18.9.1 COMPANY SNAPSHOT

18.9.2 REVENUE ANALYSIS

18.9.3 PRODUCT PORTFOLIO

18.9.4 RECENT DEVELOPMENTS

18.1 CANNABIS SEEDS USA

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 CRESCO LABS

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENTS

18.12 ECOGEN BIOSCIENCES

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENTS

18.13 ELIXINOL NORTH AMERICA LIMITED

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENTS

18.14 ENDOCA

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENT

18.15 EXTRACTAS

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 FOLIUM BIOSCIENCES

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENTS

18.17 GREENWICH BIOSCIENCES, INC.

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENTS

18.18 HARMONY

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENTS

18.19 HUMBOLDT SEED COMPANY

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 IDT AUSTRALIA

18.20.1 COMPANY SNAPSHOT

18.20.2 REVENUE ANALYSIS

18.20.3 PRODUCT PORTFOLIO

18.20.4 RECENT DEVELOPMENTS

18.21 MARY’S NUTRITIONALS, LLC

18.21.1 COMPANY SNAPSHOT

18.21.2 PRODUCT PORTFOLIO

18.21.3 RECENT DEVELOPMENT

18.22 MEDICAL MARIJUANA, INC.

18.22.1 COMPANY SNAPSHOT

18.22.2 REVENUE ANALYSIS

18.22.3 PRODUCT PORTFOLIO

18.22.4 RECENT DEVELOPMENTS

18.23 PEACE NATURALS PROJECT INC.

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 PHARMAHEMP

18.24.1 COMPANY SNAPSHOT

18.24.2 PRODUCT PORTFOLIO

18.24.3 RECENT DEVELOPMENT

18.25 PURE RATIOS

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

18.26 SEEDS FOR ME

18.26.1 COMPANY SNAPSHOT

18.26.2 PRODUCT PORTFOLIO

18.26.3 RECENT DEVELOPMENT

18.27 SEED CELLAR

18.27.1 COMPANY SNAPSHOT

18.27.2 PRODUCT PORTFOLIO

18.27.3 RECENT DEVELOPMENT

18.28 UPSTATE ELEVATOR SUPPLY CO.

18.28.1 COMPANY SNAPSHOT

18.28.2 PRODUCT PORTFOLIO

18.28.3 RECENT DEVELOPMENT

18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)

18.29.1 COMPANY SNAPSHOT

18.29.2 PRODUCT PORTFOLIO

18.29.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Список таблиц

TABLE 1 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 2 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 5 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 6 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 7 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 13 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 14 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 18 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 22 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 23 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 26 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 30 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 32 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 35 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 39 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 40 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 43 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 44 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 47 NORTH AMERICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 NORTH AMERICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 NORTH AMERICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 51 NORTH AMERICA CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 NORTH AMERICA TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 NORTH AMERICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 NORTH AMERICA CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 NORTH AMERICA CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 NORTH AMERICA CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 63 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 65 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 67 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 69 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 71 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 73 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 75 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 77 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 NORTH AMERICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 79 NORTH AMERICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 NORTH AMERICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 81 NORTH AMERICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 83 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 84 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 85 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 87 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 89 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 91 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 94 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 96 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 97 NORTH AMERICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 98 NORTH AMERICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 99 NORTH AMERICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 100 NORTH AMERICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 101 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 102 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 103 NORTH AMERICA ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 104 NORTH AMERICA PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 105 NORTH AMERICA ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 106 NORTH AMERICA APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 107 NORTH AMERICA EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 108 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 109 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 NORTH AMERICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 111 NORTH AMERICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 112 NORTH AMERICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 113 NORTH AMERICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 114 NORTH AMERICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 115 NORTH AMERICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 116 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 117 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 118 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 119 NORTH AMERICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 120 NORTH AMERICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 121 NORTH AMERICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 124 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 125 NORTH AMERICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 126 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 NORTH AMERICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 129 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 130 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 131 NORTH AMERICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 134 NORTH AMERICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 137 NORTH AMERICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 138 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 140 NORTH AMERICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 141 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 142 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 143 NORTH AMERICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 147 NORTH AMERICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 150 NORTH AMERICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 153 NORTH AMERICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 154 NORTH AMERICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 156 NORTH AMERICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 157 NORTH AMERICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 158 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 159 NORTH AMERICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 NORTH AMERICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 NORTH AMERICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 NORTH AMERICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 NORTH AMERICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 NORTH AMERICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 NORTH AMERICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 167 NORTH AMERICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 168 NORTH AMERICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 NORTH AMERICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 NORTH AMERICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 NORTH AMERICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 NORTH AMERICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 173 NORTH AMERICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 NORTH AMERICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 NORTH AMERICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 177 NORTH AMERICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 NORTH AMERICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 NORTH AMERICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 NORTH AMERICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 181 NORTH AMERICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 182 NORTH AMERICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 183 NORTH AMERICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 U.S. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 185 U.S. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 U.S. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 187 U.S. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 188 U.S. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 189 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 U.S. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 192 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 193 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 194 U.S. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 196 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 197 U.S. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 200 U.S. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 202 U.S. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 203 U.S. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 206 U.S. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 208 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 210 U.S. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 U.S. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 213 U.S. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 U.S. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 216 U.S. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 217 U.S. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 U.S. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 219 U.S. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 220 U.S. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 221 U.S. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 222 U.S. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 224 U.S. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 225 U.S. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 U.S. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 U.S. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 U.S. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 229 U.S. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 U.S. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 U.S. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 U.S. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 U.S. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 U.S. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 U.S. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 U.S. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 237 U.S. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 238 U.S. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 239 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 U.S. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 241 U.S. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 U.S. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 243 U.S. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 244 U.S. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 245 U.S. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 246 U.S. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 247 CANADA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 248 CANADA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 249 CANADA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 250 CANADA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 251 CANADA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 253 CANADA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 254 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 255 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 256 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 257 CANADA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 258 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 259 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 260 CANADA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 261 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 263 CANADA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 264 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 CANADA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 266 CANADA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 267 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 268 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 269 CANADA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 270 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 271 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 272 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 273 CANADA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 274 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 275 CANADA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 276 CANADA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 277 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 278 CANADA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 279 CANADA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 CANADA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 CANADA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 282 CANADA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 283 CANADA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 284 CANADA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 285 CANADA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 286 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 CANADA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 288 CANADA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 289 CANADA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 290 CANADA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 291 CANADA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 292 CANADA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 293 CANADA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 294 CANADA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 295 CANADA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 296 CANADA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 CANADA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 298 CANADA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 CANADA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 CANADA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 CANADA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 303 CANADA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 304 CANADA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 305 CANADA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 306 CANADA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 307 CANADA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 CANADA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 CANADA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 310 MEXICO MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 311 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 312 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 313 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 314 MEXICO OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 315 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 316 MEXICO DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 317 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 319 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 320 MEXICO MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 321 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 323 MEXICO VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 324 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 326 MEXICO WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 328 MEXICO CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 329 MEXICO CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 331 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 332 MEXICO GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 333 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 336 MEXICO PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 338 MEXICO MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 339 MEXICO MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 MEXICO CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 342 MEXICO CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 343 MEXICO BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 MEXICO MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 345 MEXICO SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 346 MEXICO MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 347 MEXICO MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 348 MEXICO MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 350 MEXICO PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 351 MEXICO ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 MEXICO MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 MEXICO NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 MEXICO APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 MEXICO EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 356 MEXICO INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 357 MEXICO CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 358 MEXICO ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 359 MEXICO WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 360 MEXICO ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 361 MEXICO EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 362 MEXICO DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 363 MEXICO MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 364 MEXICO AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 365 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 MEXICO MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 367 MEXICO ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 368 MEXICO MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 369 MEXICO MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 370 MEXICO MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 371 MEXICO MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 372 MEXICO B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

Список рисунков

FIGURE 1 NORTH AMERICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA MEDICAL CANNABIS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA MEDICAL CANNABIS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA MEDICAL CANNABIS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA MEDICAL CANNABIS MARKET: SEGMENTATION

FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE NORTH AMERICA MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICAL CANNABIS MARKET IN 2023 AND 2030

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA MEDICAL CANNABIS MARKET AND IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 14 NORTH AMERICA IS THE FASTEST-GROWING MARKET FOR MEDICAL CANNABIS MANUFACTURERS IN THE FORECAST PERIOD OF 2023 TO 2030

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA MEDICAL CANNABIS MARKET

FIGURE 16 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2022

FIGURE 17 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)

FIGURE 18 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)

FIGURE 19 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 20 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, 2022

FIGURE 21 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)

FIGURE 22 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)

FIGURE 23 NORTH AMERICA MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE

FIGURE 24 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022

FIGURE 25 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)

FIGURE 26 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)

FIGURE 27 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE

FIGURE 28 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION, 2022

FIGURE 29 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)

FIGURE 30 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)

FIGURE 31 NORTH AMERICA MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 32 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022

FIGURE 33 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)

FIGURE 34 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)

FIGURE 35 NORTH AMERICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 36 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022

FIGURE 37 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)

FIGURE 38 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)

FIGURE 39 NORTH AMERICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 40 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, 2022

FIGURE 41 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 42 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)

FIGURE 43 NORTH AMERICA MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 44 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 45 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 46 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 47 NORTH AMERICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 NORTH AMERICA MEDICAL CANNABIS MARKET: SNAPSHOT (2022)

FIGURE 49 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022)

FIGURE 50 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)

FIGURE 51 NORTH AMERICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)

FIGURE 52 NORTH AMERICA MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)

FIGURE 53 NORTH AMERICA MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

The North America Medical Cannabis Market is projected to grow at a CAGR of 23.2% during the forecast period by 2030.
The North America Medical Cannabis Market is segmented on the basis of product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The major players in the North America Medical Cannabis Market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Global Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, etc.
The countries covered in the North America Medical Cannabis Market are U.S., Canada, and Mexico.